Nose Bleeds

Nosebleeds (Epistaxis): A Nutrition and Natural Health Reference

Definition and Clinical Overview

Epistaxis is defined as bleeding from the nasal cavity. It is one of the most frequent emergencies encountered in otorhinolaryngology, affecting individuals of all ages and ranging from minor, self-limiting bleeding to severe, life-threatening hemorrhage. Approximately 60% of people experience at least one episode during their lifetime, though only a small percentage require medical intervention. Epistaxis is not a disease itself; it is a symptom of underlying local, systemic, environmental, or vascular pathology.

Epistaxis exhibits a bimodal age distribution, being most common before age 10 and between ages 45 and 65. It can be classified into anterior, which is more common, and posterior, which is less frequent but often more severe and likely to require medical intervention.

Anatomy and Presentation

The nose is a highly vascular organ with a large surface area secondary to intense heating and humidification requirements, which also predisposes it to bleeding. The nasal blood supply comes from both internal and external carotid artery systems. The external carotid system provides blood supply through the maxillary artery to the sphenopalatine artery, which enters the nose near the posterior end of the middle turbinate and divides to supply both the septum and the lateral wall. These branches anastomose with branches of the anterior and posterior ethmoidal arteries, which come from the internal carotid by way of the ophthalmic artery.

The source of 90% of anterior nosebleeds is within Kiesselbach plexus (also known as Little's area) on the anterior nasal septum. There are five named vessels whose terminal branches supply the nasal cavity, and their watershed areas converge in the anterior nasal septum, comprising Kiesselbach plexus. This lies at the entrance to the nasal cavity and is subject to extremes of heat, cold, and high and low moisture; it is easily traumatized, and the mucosa over the septum in this area is fragile, making this the site of most epistaxis.

Epistaxis represents the final clinical manifestation of vascular disruption within the nasal mucosa under conditions where local vessel integrity, systemic coagulation mechanisms, or hemodynamic stability are compromised. Although clinically simple in many cases, its biological basis is complex and involves vascular anatomy, endothelial biology, inflammatory mediators, neurovascular regulation, and systemic hematologic factors.

Clinically, nosebleeds present in varying ways. Nosebleeds usually involve one nostril, but occasionally both nostrils are involved. If one nostril becomes partially blocked with a blood clot, the blood might flow out the other nostril or down the back of the throat. In a posterior nosebleed, large amounts of blood typically flow down the back of the throat, and posterior bleeds usually bleed significantly more than anterior ones.

Body Systems Involved

• Vascular system: The plexus of vessels known as Kiesselbach's plexus is particularly vulnerable to digital as well as direct blunt trauma. These vessels run beneath a delicate mucosa that is supported by and tightly adherent to a rigid structure of bone and cartilage that provides little cushioning for traumatic forces.
• Hematologic/coagulation system: Inherited bleeding diatheses, including hemophilia and von Willebrand disease, as well as acquired coagulopathies — often secondary to medications or liver disease — may cause initial or recurrent epistaxis.
• Cardiovascular system: A significant association of epistaxis with hypertension strongly emphasizes the role of vascular fragility and unregulated systolic pressures in the nasal mucosa.
• Immune and respiratory system: Conditions such as allergic rhinitis and chronic sinusitis are associated with increased likelihood of epistaxis.
• Endocrine/metabolic system: Hypertension and diabetes mellitus may induce atherosclerotic changes in the nasal vessels, making them friable and more at risk for bleeding.
• Connective tissue: The nasal mucosa's structural integrity depends on collagen, whose synthesis is nutrient-dependent — particularly on vitamin C — making connective tissue health a relevant biological domain.

Contributing and Associated Factors

Local Factors

Causes of epistaxis can be divided into local causes (e.g., trauma, mucosal irritation, septal abnormality, inflammatory diseases, tumors) and systemic causes (e.g., blood dyscrasias, arteriosclerosis, hereditary hemorrhagic telangiectasia). Local trauma is the most common cause, followed by facial trauma, foreign bodies, nasal or sinus infections, and prolonged inhalation of dry air.

Seasonal dryness during winters is an important environmental factor predisposing to mucosal cracking and spontaneous bleeding, while trauma-related epistaxis and deviated nasal septum have emerged as frequent contributory factors by altering nasal airflow and mucosal contact. The deviated septum often results in turbulent airflow, drying the mucosa over the convexity and leading to mucosal erosion and bleeding.

Systemic and Demographic Factors

Male gender, older age, peripheral vascular disease, cardiovascular disease, and a previous history of epistaxis were identified as independent predictors of epistaxis requiring emergency department admission in a prospective study (male gender: OR=2.57; cardiovascular disease: OR=3.91; prior history: OR=5.53).

In a cross-sectional study of 500 patients, the highest association of epistaxis was found with hypertension (42.8%), with males showing a higher frequency. Other reasons for the association with older age include vascular fragility, thinning of the nasal mucosa, increased use of medications, and prevalence of hypertension and chronic health conditions.

Systemic conditions including hypertension, coagulation disorders, diabetes, heart failure, anemia, and liver disorders can play a role in the development of epistaxis, as can anticoagulant and intranasal medication use.

Environmental Factors

A large study (20,234 patients) found that temperature, humidity, maximum wind speed, and sunshine duration were associated with epistaxis in preschool-aged children, while average wind speed, particulate matter, temperature, humidity, sunshine duration, and sulfur dioxide concentration were associated with epistaxis in school-aged children.

A German study found that the rate of patients receiving a first epistaxis diagnosis at an otolaryngologic practice was lowest in summer, peaking in February–April. The study, which involved 114 otolaryngologic practices, reported a rate of 7.22 epistaxis patients per practice in August versus a peak rate of 14.89 patients per practice in February.

Hereditary Hemorrhagic Telangiectasia (HHT)

Hereditary haemorrhagic telangiectasia (HHT) is a heterogeneous autosomal dominant disorder of angiogenesis with an estimated prevalence of 1:5,000 to 1:10,000. It results from pathogenic variants in one of four genes (ENG, ACVRL1, SMAD4, GDF2) that encode proteins in the BMP/TGF-beta signalling pathway, resulting in mucocutaneous telangiectasias and visceral arteriovenous malformations. Recurrent epistaxis, which frequently results in iron deficiency anaemia and impaired quality of life, is the most frequent complication of HHT.

Nutritional Deficiencies Associated with Epistaxis

Vitamin C (Ascorbic Acid)

The rationale for vitamin C's connection to nosebleeds comes from its established role in supporting collagen synthesis and maintaining the integrity of blood vessel walls. Deficiency in vitamin C can lead to weakened capillaries, making them more prone to rupture and bleeding — a phenomenon observed in scurvy, where spontaneous bleeding (including from the nose) is a classic symptom.

In children, recurrent epistaxis is not uncommon, and in the majority of cases it is difficult to identify underlying causes. Researchers have considered the breakdown or weakness of vascular integrity of the nasal capillary vessel wall as an important factor in recurrent epistaxis, and noted that vitamin C, which plays an important role in the synthesis of collagen fiber, could influence this process.

While biological plausibility exists, clinical evidence for vitamin C supplementation specifically to treat or prevent nosebleeds in otherwise healthy individuals is limited. Some case reports and small observational studies suggest that vitamin C supplementation may reduce the frequency of nosebleeds, especially in children or people with a tendency toward fragile capillaries. A few pediatric case series note improvement in recurrent epistaxis with vitamin C, but these are not large, controlled trials. Overall, robust, large-scale clinical trials confirming vitamin C's efficacy for nosebleeds are lacking.

Vitamin K

Vitamin K is essential for the synthesis of coagulation proteins. It is a co-factor for vitamin K-dependent carboxylation, which allows coagulation factors to bind calcium ions and further facilitates the cascade pathways. Vitamin K deficiency impairs the coagulation process, leading to issues with bleeding.

Vitamin K is essential for the synthesis of several clotting factors in the liver, including factors II, VII, IX, and X. Deficiency impairs blood clotting and increases the risk of spontaneous bleeding, including from the nasal mucosa. Medical literature and clinical guidelines note that vitamin K supplementation is indicated in patients with bleeding tendencies due to vitamin K deficiency, which may be caused by malabsorption, certain medications (like warfarin), liver disease, or dietary insufficiency.

However, most nosebleeds are not caused by vitamin K deficiency but by local trauma, dry air, or underlying vascular fragility. In these typical cases, vitamin K supplementation does not provide benefit. In adults, vitamin K deficiency is uncommon but may occur with inadequate intake, malabsorption, or altered metabolism. Poor dietary intake, particularly in individuals with restricted diets, malnutrition, or prolonged periods of no oral intake, is a common contributing factor.

Iron

Research on HHT patients suggests that those with nosebleeds occurring less than daily may be reasonably expected to achieve their extra iron intake through diet alone, but daily nosebleeds are likely to require formal iron supplements, whether or not there are additional hemorrhagic losses. This is important for clinicians as epistaxis is not considered an important clinical question when evaluating iron-deficient individuals.

In HHT patients, the mean daily iron intake was 8.46 ± 2.78 mg. In the comprehensive management of HHT, a healthy and balanced diet, with increased consumption of dietary items with a high iron content, should be encouraged.

Nutrients, Herbs, and Natural Ingredients: Evidence Summary

Citrus Bioflavonoids (Diosmin, Hesperidin, Rutin, Naringenin)

Traditional Use

Citrus bioflavonoids and related substances have been widely used in Europe to treat diseases of the blood vessels and lymph system, including hemorrhoids, chronic venous insufficiency, leg ulcers, easy bruising, nosebleeds, and lymphedema following breast cancer surgery. These substances were historically known as "vitamin P" due to their role in maintaining vascular permeability and integrity.

Scientific Evidence

The efficacy and safety of a veno-active flavonoid fraction (S 5682) consisting of micronized diosmin (90%) and hesperidin (10%) were studied in 100 patients with symptomatic capillary fragility in a double-blind, randomized, placebo-controlled trial. Treatment lasted 6 weeks (two daily tablets). Compared to placebo, capillary resistance was significantly higher in the S 5682 group at week 4 (219 ± 10 mmHg vs. 159 ± 8 mmHg; p < 0.001) and week 6 (261 ± 12 mmHg vs. 163 ± 9 mmHg; p < 0.001). This resulted in a significant improvement of symptoms of capillary fragility — including spontaneous ecchymosis, epistaxis, purpura, petechiae, gingivorrhagia, metrorrhagia, and conjunctival haemorrhage — in treated patients (p < 0.001).

A double-blind, placebo-controlled study of 96 people with fragile capillaries found that a combination of the bioflavonoids diosmin and hesperidin decreased symptoms of capillary fragility such as nosebleeds and bruising. In this six-week trial, participants (41 percent of whom had problems with nosebleeds) took two tablets daily of the bioflavonoid combination or placebo.

Scientific evidence suggests that certain bioflavonoids, particularly rutin, hesperidin, and quercetin, can help strengthen capillary walls and reduce capillary permeability and fragility. These effects have been demonstrated in both animal and human studies, especially in conditions such as chronic venous insufficiency and hemorrhoids. Mechanistically, bioflavonoids are thought to work by stabilizing collagen and elastin in blood vessel walls, reducing oxidative stress, and modulating inflammation.

Evidence strength: Moderate — one small-to-medium randomized controlled trial (n=100) directly demonstrated improvement in epistaxis as part of a capillary fragility syndrome. The study population was not limited to epistaxis patients, and replication in larger, epistaxis-specific trials is absent. Evidence for rutin and quercetin specifically is largely mechanistic or derived from studies in related conditions (chronic venous insufficiency, hemorrhoids).

Oligomeric Proanthocyanidins (OPCs) and Bilberry

Traditional Use

Related chemicals called anthocyanosides are present in high concentrations in the herb bilberry. Like OPCs, anthocyanosides may strengthen capillaries through their effects on collagen.

Scientific Evidence

One rather poorly designed double-blind study of 37 people, most of whom had fragile capillaries, found that OPCs were more effective than placebo in decreasing capillary fragility; however, the study authors left many questions unanswered in their report, making it hard to determine how seriously to take their results, and they did not address nosebleeds specifically.

Other suggested treatments include bilberry and OPCs, which may strengthen collagen and support blood vessel integrity, although robust evidence specifically linking them to nosebleed prevention is limited.

Evidence strength: Preliminary and weak — existing data relate to capillary fragility broadly, not to epistaxis specifically. No high-quality human trials exist directly testing OPCs or bilberry for nosebleed reduction.

Shepherd's Purse (Capsella bursa-pastoris)

Traditional Use

In ancient Greece, shepherd's purse was commonly used to heal wounds, while in China, its use dates back over 2,000 years for culinary and medicinal purposes. Shepherd's purse has been applied topically or taken internally to stop nosebleeds and accelerate wound healing due to its ability to constrict blood vessels. The herb contains compounds such as flavonoids, glycosides, and tannins, which have astringent and coagulant properties. These properties are associated with stopping nosebleeds, reducing heavy menstrual bleeding, and treating minor cuts and wounds. A simple infusion of the dried herb can be applied topically or taken internally.

Scientific Evidence

Shepherd's purse is used for nosebleeds, premenstrual syndrome (PMS), abnormally heavy bleeding during menstrual periods, and other conditions, but there is no good scientific evidence to support these uses. Studies have been done on shepherd's purse for its hemostatic and choleretic actions, but they are in Russian and have not been translated into English. Human studies are non-existent in support of the clinical and traditional uses of shepherd's purse.

Studies support its traditional use as a hemostatic agent, particularly for heavy menstrual bleeding, but more robust clinical trials are needed. Animal and in vitro studies indicate promising antimicrobial and anti-inflammatory effects, warranting further investigation.

Evidence strength: Weak — traditional use is extensive across multiple cultures, but controlled human clinical trials for nosebleed specifically are absent. Preliminary in vitro and animal data are promising but not sufficient to characterize clinical benefit.

Yarrow (Achillea millefolium)

Traditional Use

Yarrow has a long history across European and Indigenous North American herbal traditions as a hemostatic agent applied directly to wounds and bleeding tissue, including the nasal passages. The hemostatic action of yarrow is described as cooling, and suited to conditions where the blood is red and haemorrhaging. Traditional preparations include topical application of the fresh leaf and internal use of tea or tincture.

Scientific Evidence

No human clinical trials specifically evaluating yarrow for epistaxis have been identified in the peer-reviewed literature. Its traditional hemostatic use is supported by in vitro research on its constituent flavonoids and tannins, but controlled clinical data for nosebleeds are lacking.

Evidence strength: Traditional use well-documented; clinical evidence for epistaxis specifically is absent.

Bromelain and Proteolytic Enzymes

Traditional and Proposed Use

Proteolytic enzymes (such as bromelain) are thought to help stabilize capillaries. Bromelain, derived from pineapple (Ananas comosus), is used in some naturopathic traditions to support vascular and connective tissue integrity.

Scientific Evidence

No studies have directly addressed the potential value of bromelain for nosebleeds. Mechanistic plausibility exists through its effects on connective tissue, but epistaxis-specific clinical data are absent.

Evidence strength: Mechanistic/theoretical only; no clinical evidence for epistaxis.

Natural Ingredients That May Exacerbate Nosebleeds

Several natural substances with antiplatelet or anticoagulant properties appear in the literature as potential contributors to increased bleeding, including nosebleeds.

Some dietary supplements contain chemicals that may prolong bleeding. Examples include dong quai, feverfew, garlic, ginger, ginkgo biloba, ginseng, and vitamin E.

In a dietary survey of HHT patients, the most frequently reported items exacerbating epistaxis were alcohol and spices. Remaining foods reported to worsen epistaxis were found to be high in salicylates (including red wine, spices, chocolate, coffee, and certain fruits), natural antiplatelet activity (garlic, ginger, ginseng, ginkgo biloba, and vitamin E), or omega-3 acids (oily fish, salmon).

A comprehensive review of evidence on dietary supplement bleeding risks found that garlic and hawthorn supplementation is strongly associated with surgical bleeding independent of anticoagulants. Cordyceps sinensis, echinacea, and aloe vera are loosely associated with surgical bleeding. In patients on anticoagulants, ginkgo biloba, chondroitin-glucosamine, melatonin, turmeric, bilberry, chamomile, fenugreek, milk thistle, and peppermint are associated with bleeding risk.

It is important to note that evidence pertaining to these agents and epistaxis specifically is largely derived from HHT populations (who have structurally abnormal vessels) or from general antiplatelet pharmacology, not from studies in individuals with typical idiopathic nosebleeds. Extrapolating this data to healthy individuals requires caution.

Dietary and Lifestyle Factors

Humidity and Environmental Moisture

Lifestyle and dietary factors were generally detrimental to epistaxis in HHT patients, but room humidification, nasal lubrication, and saline treatments were all reported as beneficial (95% confidence intervals greater than zero). Topical saline has been shown to reduce epistaxis severity score, compared to baseline, in a randomized controlled trial of multiple topical therapies.

Dietary Patterns and Food Items

Among 149 HHT patients evaluated by food-frequency questionnaire, 26 (18%) reported dietary items that improved epistaxis (mostly blueberries and red fruits, green vegetables, and legumes), while 38 (26%) reported some dietary items that exacerbated epistaxis (spices, chocolate, alcohol, strawberries, and ginger). Dietary modifications were reported in up to 58% of cases.

In addition, most fruits — especially berry fruits and dried fruits — many vegetables, tea, and honey contain salicylate, although functional evidence of antiplatelet activities has generally not been reported to date.

Alcohol

In dietary surveys, alcohol was the most frequently reported item exacerbating epistaxis, cited by 45 participants (6.8% of a study population of HHT patients). Alcohol induces peripheral vasodilation and, at higher doses, impairs platelet function, both of which are plausible mechanisms for increasing nasal mucosal bleeding.

Iron Adequacy and Anemia

Recurrent epistaxis, which frequently results in iron deficiency anaemia and impaired quality of life, is the most frequent complication of HHT. Patients with recurrent epistaxis may also be more susceptible to developing anemia. The relationship between epistaxis and iron is therefore bidirectional: iron deficiency may impair tissue repair and hemostasis, while chronic epistaxis can itself cause or worsen iron depletion.

Smoking and Air Quality

Average wind speed, particulate matter, temperature, humidity, sunshine duration, and sulfur dioxide concentration were associated with epistaxis in school-aged children, highlighting the role that air quality and pollutants play in mucosal irritation and nosebleed frequency. Smoking is known to dry and irritate nasal mucosa and is listed among lifestyle factors discussed in atrophic rhinitis literature, where hygiene, a well-balanced diet, smoking cessation, and other conservative approaches are central to management.

Nasal Hygiene and Hydration

Keeping nasal passages moist — through adequate systemic hydration and humidified indoor environments — is a widely endorsed principle in ENT and natural-health literature to reduce the frequency of dryness-induced anterior epistaxis. Traumatic events contributing to epistaxis would include nose picking, foreign body insertion, desiccation due to breathing poorly humidified air (common in winter months), cocaine snorting, and direct blunt trauma.

Summary of Evidence Levels

• Vitamin K: Well-established role in coagulation (NIH/StatPearls, peer-reviewed literature). Supplementation is evidence-based only when deficiency or drug-induced deficiency (e.g., warfarin) is documented. Evidence for routine use in idiopathic epistaxis: not supported.
• Vitamin C: Sound mechanistic basis through collagen synthesis and capillary integrity. Deficiency clearly contributes to fragile capillaries (as in scurvy). Small pediatric observational studies suggest benefit in recurrent idiopathic epistaxis, but no large RCTs exist. Evidence: modest/preliminary.
• Diosmin + Hesperidin (bioflavonoids): One small-to-medium RCT (n=100) demonstrates significant reduction in capillary fragility symptoms including epistaxis (Galley & Thiollet, Int Angiol, 1993). Largest and most direct evidence base in the natural-health domain for this condition. Evidence: moderate, with important limitations (small sample, older trial, mixed symptom population).
• OPCs / Bilberry: Mechanistic plausibility; one poorly designed small trial for capillary fragility generally. Evidence: weak.
• Shepherd's Purse: Traditional use robust across cultures; no qualifying human clinical trials for epistaxis. Evidence: traditional/anecdotal only.
• Yarrow: Traditional hemostatic use well-documented; clinical trial evidence for epistaxis absent. Evidence: traditional/anecdotal only.
• Garlic, Ginkgo, Ginger, Ginseng, Vitamin E, Omega-3s: Evidence points toward potential pro-bleeding effects via antiplatelet activity. Persons prone to nosebleeds, especially with underlying vascular fragility (e.g., HHT), may benefit from restricting these supplements and foods. Evidence: observational surveys and pharmacological data; epistaxis-specific RCTs absent.

References

• Walker TWM et al. Epistaxis: A Common Problem. PMC / NIH.
• Tunkel DE et al. Epistaxis. StatPearls. NCBI Bookshelf / NIH.
• Epistaxis. Clinical Methods. NCBI Bookshelf / NIH.
• Kucik CJ, Clenney T. Epistaxis: Practice Essentials, Anatomy, Pathophysiology. Medscape.
• Ross A et al. Risk Factors and Management for Epistaxis in a Hospitalized Adult Sample. Spartan Med Res J. 2022;7(2):37760.
• Exploring Etiological Risk Factors and Their Association With Epistaxis: A Cross-Sectional Study on 500 Patients. Cureus / PMC. 2025.
• Seidel DU et al. Risk factors for the occurrence of epistaxis: Prospective study. PubMed. 2017.
• Abrich V et al. Risk Factors for Recurrent Spontaneous Epistaxis. Mayo Clinic Proceedings. 2014.
• Smith SA, Sharman T. Vitamin K. StatPearls. NCBI Bookshelf / NIH.
• Vitamin K Deficiency in Neonates and Adults. StatPearls. NCBI Bookshelf / NIH.
• Takahashi D et al. Vitamin K Deficiency Bleeding in Infancy. PMC / NIH. 2020.
• Galley P, Thiollet M. A double-blind, placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility. Int Angiol. 1993;12(1):69–72.
• Natural treatments for nosebleeds. EBSCO Research Starters: Complementary and Alternative Medicine.
• Citrus bioflavonoids as dietary supplements. EBSCO Research Starters: Nutrition and Dietetics.
• Millar CL et al. Hesperidin: A Review on Extraction Methods, Stability and Biological Activities. PMC / NIH. 2022.
• Govani FS et al. Hemorrhage-Adjusted Iron Requirements, Hematinics and Hepcidin Define Hereditary Hemorrhagic Telangiectasia as a Model of Hemorrhagic Iron Deficiency. PLOS One. 2013.
• Dietary iron intake and anemia: food frequency questionnaire in patients with hereditary hemorrhagic telangiectasia. PMC / NIH. 2020.
• Hitchings AW et al. 7-day weighed food diaries suggest patients with hereditary hemorrhagic telangiectasia may spontaneously modify their diet to avoid nosebleed precipitants. ResearchGate. 2017.
• Levy JH et al. Dietary supplements and bleeding. PMC / NIH. 2022.
• Environmental factors differentially affect epistaxis among preschool and school-aged children. PMC / NIH. 2023.
• The effect of the COVID-19 pandemic on epistaxis and anaemia in patients with hereditary haemorrhagic telangiectasia. PMC / NIH. 2025.
• Nosebleed (Epistaxis). Harvard Health Publishing.
• Park IS et al. Urinary Vitamin C Loading Test and Therapeutic Effect of Vitamin C in Children with Idiopathic Recurrent Epistaxis. Clinical and Experimental Pediatrics. 1993.
• Shepherd's Purse. WebMD Vitamins and Supplements.
• Epistaxis (Nosebleed) Management. CureHHT International Guidelines.
• Epistaxis. GeekyMedics Clinical Guide. 2025.